Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
9 pending office actions • 5 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready
Remix Therapeutics Inc. is managing 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 7 pending office actions are spread across 7 distinct examiners. The portfolio spans 4 distinct art units. WHITE, DAWANNA SHAR-DAY is the busiest examiner, though they only hold 1 busiest examiner pending action.
The ratio of 7 distinct examiners to 7 pending office actions shows a lack of examiner overlap. This requires the company to adapt to 7 different examination styles. With 4 distinct art units involved, the 7 pending office actions cover different sectors within Biotechnology & Pharmaceuticals. The 1 busiest examiner pending action for WHITE, DAWANNA SHAR-DAY indicates that the workload is distributed across the examiner pool.
Practitioners should prepare for a prosecution landscape across 4 distinct art units. Because there are 7 distinct examiners, no single examiner's preferences will dominate the portfolio's outcome. The 7 pending office actions represent the administrative commitment across multiple USPTO divisions, requiring a coordinated approach to maintain consistency across the 4 distinct art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (11%) |
| Double-patenting only | 1 (11%) |
| Double-patenting + other | 4 (44%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, DAWANNA SHAR-DAY | 1 | 62.5% | +23.3% |
| SHIAO, REI TSANG | 1 | 79.8% | -33.6% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 65.8% | +51.3% |
| MOORE, SUSANNA | 1 | 68.1% | +31.6% |
| MCDOWELL, BRIAN E | 1 | 74.1% | +30.8% |
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.4% | +25.6% |
| GONZALEZ, LUISALBERTO | 1 | 59.4% | +47.2% |
| CHICKS, ASHLI ARIANA | 1 | 60.6% | +50.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688100 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | VISHNYAKOVA, ELENA VLADIMIROVNA | — |
| 17802866 | THIOPHENYL DERIVATIVES USEFUL FOR MODULATING NUCLEIC ACID SPLICING | GONZALEZ, LUISALBERTO | — |
| 17802833 | FUSED BICYCLIC COMPOUNDS USEFUL FOR MODULATING NUCLEIC ACID SPLICING | CHICKS, ASHLI ARIANA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18014059 | 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TRE | MCDOWELL, BRIAN E | 87d overdue |
| 18014057 | 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES | MOORE, SUSANNA | 78d |
| 18713561 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | WHITE, DAWANNA SHAR-DAY | — |
| 18688100 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | VISHNYAKOVA, ELENA VLADIMIROVNA | — |
| 17917868 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | NOTTINGHAM, KYLE GREGORY | — |
| 17802702 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | MAHLUM, JONATHAN DAVIS | — |
| 17802866 | THIOPHENYL DERIVATIVES USEFUL FOR MODULATING NUCLEIC ACID SPLICING | GONZALEZ, LUISALBERTO | — |
| 17802833 | FUSED BICYCLIC COMPOUNDS USEFUL FOR MODULATING NUCLEIC ACID SPLICING | CHICKS, ASHLI ARIANA | — |
| Art Unit | Apps |
|---|---|
| 1624 | 3 |
| 1691 | 2 |
| 1621 | 1 |
| 1625 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18713561 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | WHITE, DAWANNA SHAR-DAY | — | §102§103§112DP | Non-Final OA | — | Pending | May 24, 2024 |
| 18688081 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | SHIAO, REI TSANG | 1691 | DP | Final Rejection | — | Pending | Feb 29, 2024 |
| 18688100 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103§112 | Non-Final OA | — | Pending | Feb 29, 2024 |
| 18014057 | 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES | MOORE, SUSANNA | 1624 | §112DPOther | Non-Final OA | 78d | Pending | Dec 30, 2022 |
| 18014059 | 2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TRE | MCDOWELL, BRIAN E | 1624 | §112 | Final Rejection | 87d overdue | Pending | Dec 30, 2022 |
| 17917868 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | NOTTINGHAM, KYLE GREGORY | 1621 | §112DP | Non-Final OA | — | Pending | Oct 07, 2022 |
| 17802702 | PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING | MAHLUM, JONATHAN DAVIS | 1625 | §112DP | Final Rejection | — | Pending | Aug 26, 2022 |
| 17802866 | THIOPHENYL DERIVATIVES USEFUL FOR MODULATING NUCLEIC ACID SPLICING | GONZALEZ, LUISALBERTO | 1624 | §102§103Other | Non-Final OA | — | Pending | Aug 26, 2022 |
| 17802833 | FUSED BICYCLIC COMPOUNDS USEFUL FOR MODULATING NUCLEIC ACID SPLICING | CHICKS, ASHLI ARIANA | 1626 | §102§103 | Non-Final OA | — | Pending | Aug 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial